AstraZeneca joins Robert A. Winn Awards as funding partner to expand clinical trial diversity and medical student training

AstraZeneca joins the Robert A. Winn Awards to fund medical students in the Winn CIPP, promoting diversity and community engagement in clinical research.

By: AXL Media

Published: Mar 31, 2026, 11:32 AM EDT

Source: Information for this report was sourced from The Robert A. Winn Excellence in Clinical Trials Award Program (Winn Awards)

Strategic Expansion of Clinical Research Training

The Robert A. Winn Excellence in Clinical Trials Award Program (Winn Awards) has announced a significant expansion of its resource base with the addition of AstraZeneca as a primary funding partner. This collaboration is specifically designed to bolster the Winn Clinical Investigator Pathway Program (Winn CIPP), an intensive summer initiative that prepares medical students for careers in clinical research. By joining existing partners like Gilead Sciences and Amgen, AstraZeneca is helping to scale a framework that addresses the historical lack of diversity in medical studies, ensuring that future life-saving therapies are tested across a representative spectrum of the human population.

The Architecture of the Investigator Pathway

The Winn CIPP operates as a six-week immersive service-learning experience tailored for medical students who demonstrate a passion for expanding healthcare access. The program prioritizes applicants from disadvantaged backgrounds, aligning with the American Association of Medical Colleges' mission to diversify the medical field. Participants are placed at active clinical research sites where they engage in a multifaceted curriculum that balances technical data collection with community-level outreach. This dual focus ensures that students do not just learn the mechanics of a trial, but also the social and ethical complexities of engaging medically underrepresented communities.

Core Components of the Six-Week Immersion

During the program, students rotate through three fundamental pillars of clinical investigation: hands-on research, community engagement, and leadership development. The research component involves collaborative, team-based projects under the supervision of site leads, while the engagement aspect focuses on designing patient education and needs assessments. Perhaps most critically, the leadership development pillar provides direct mentorship from established site leaders and early-stage investigators. This structured approach is designed to transform medical students into "clinical trialists" who possess the cultural competency required to recruit and retain diverse patient cohorts.